Remerciements au Dr Thibault Schoell (Centre Cardiologique du Nord) pour les photographies.

Références :

1.     Vahanian A., Beyersdorf F., Praz F., et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2021;60(4):727–800. Doi: 10.1093/ejcts/ezab389.

2.     VARC-3 WRITING COMMITTEE:, Généreux P., Piazza N., et al. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol 2021. Doi: 10.1016/j.jacc.2021.02.038.

3.     Ruiz CE., Hahn RT., Berrebi A., et al. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. Journal of the American College of Cardiology 2017;69(16):2067–87. Doi: 10.1016/j.jacc.2017.02.038.

4.     Pibarot P, Herrmann HC, Wu C et al. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Aug 2;80(5):545-561. doi: 10.1016/j.jacc.2022.06.002.

5.     Zoghbi, William A. et al. Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography Journal of the American Society of Echocardiography, Volume 37, Issue 1, 2 - 63

6.     Ferstl P, Achenbach S, Marwan M, et al. Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI). Int J Cardiol. 2023 Sep 1;386:104-108. doi: 10.1016/j.ijcard.2023.05.034. Epub 2023 May 25. PMID: 37244382.